Overall, these results indicated that the PBMCs of recovered COVID-19 patients contained specific populations of T cells with high reactivity to SARS-CoV-2 S protein, of which the RBD region might induce a relatively lower level of T cell responses. The gene discussed is PROS1; the disease is COVID-19.